Free Biopharma Stock Content

Summary The 63rd annual American Society of Hematology meeting takes place from December 11-14, 2021 online and in person at the Georgia...

$XBI $126.31 +0.1% Pipeline Updates $CRTX -7.4% Cortexyme’s Atuzaginstat Slowed Cognitive Decline in Participants With Alzheimer’s...

$XBI $126.19 -1.9% Covid Updates $VALN +24.3% Valneva Announces European Commission Approval of Advance Purchase Agreement for up to 60...

$XBI $128.63 -1.44% Covid Updates $BNTX -6.7% & $PFE -2.2% Pfizer and BioNTech Submit Request to Amend U.S. FDA Emergency Use...

$XBI $130.51 -0.61% Covid Updates $COCP +3.6% Cocrystal Pharma’s SARS-CoV-2 Main Protease Inhibitors Demonstrate Pan-viral Activity...

$XBI $131.32 -1.42% Covid Updates $OCGN Ocugen, Inc. Announces Submission of Emergency Use Authorization Request to the US FDA for...

Summary The Society for Immunotherapy of Cancer (SITC) annual conference is being held in person and virtually from Nov 10-14, 2021 in...

$XBI $133.21 -0.70% Covid Updates $VERA -6.6% US Food and Drug Administration Declines Emergency Use Authorization for ZYESAMI®...

$XBI $134.15 +2.2% Covid Updates $SRNE +4.0% Sorrento Receives Brazilian Health Regulatory Agency (ANVISA) Approval for COVISTIX™...

$XBI $131.26 +1.29% Covid Updates $ABCL +4.1% Lilly to Supply 614,000 Additional Doses of AbCellera-Discovered Bamlanivimab Together with...

$XBI $129.59 +3.83% Covid Updates $COCP +5.9% Cocrystal Pharma Submits Pre-Investigational New Drug Briefing Package to the FDA for...

$XBI $124.81 -1% Covid Updates $PFE & $BNTX Pfizer and BioNTech Receive First U.S. FDA Emergency Use Authorization of a COVID-19 Vaccine...

$XBI $126.17 +3.5% Pipeline Updates $GILD Gilead Announces Clinical Trial Collaboration With Merck to Evaluate Trodelvy® (sacituzumab...

$XBI $122.22 -1.44% Covid Updates $SRNE -0.6% Sorrento Announces Encouraging Results From Two Phase 2 Studies of Abivertinib For...

$XBI $124.01 -0.31% Covid Updates $PFE +0.9% & BNTX -0.9% FDA Advisory Committee Votes in Favor of Granting Emergency Use Authorization...

$XBI $124.39 +0.17% Covid Updates $MRNA +7.1% Moderna Announces Positive Top Line Data from Phase 2/3 Study of COVID-19 Vaccine in...

$XBI $124.18 +0.27% Covid Updates $MRNA U.S. CDC Advisory Committee on Immunization Practices Recommends Booster Vaccination with...

$XBI $123.84 +0.47% Covid Updates $COCP +4.5% Cocrystal Pharma to Present Data from its Oral and Intranasal COVID-19 Therapeutics...

$XBI $123.26 +0.34% Covid Updates $MRNA -0.2% Moderna Announces FDA Authorization of a Booster Dose of Moderna’s COVID-19 Vaccine in...

$XBI $123.68 +1.0% Covid Updates $NVAX -3.4% Novavax Statement on Initial Com-COV2 Phase 2 Clinical Trial Results Presented at World...